Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 4NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Uveal Melanoma 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Liver Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × NSC 366140 × Clear all
NCT00002656 2013-04-29

Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003802 2012-12-17

Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
Dermatologic

Uveal Melanoma, Melanoma

NCT00002585 2012-03-12

Pyrazoloacridine in Treating Women With Metastatic Breast Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
20 enrolled
Breast

Breast Neoplasms

NCT00003714 2012-02-22

Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡